Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Raynauds Disease Therapeutics Report H2 2016 - Pipeline Review of 4 Companies & 6 Molecules - Research and Markets

Research and Markets
Posted on: 28 Sep 16

Research and Markets has announced the addition of the "Raynauds Disease - Pipeline Review, H2 2016" report to their offering.

Raynauds Disease pipeline therapeutics constitutes close to 6 molecules, which approximately 6 molecules are developed by companies. Our latest report Raynauds Disease - Pipeline Review, H2 2016, outlays comprehensive information on the therapeutics under development for Raynauds Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Raynauds Disease Raynauds disease is a common condition that affects the blood supply to certain parts of the body, usually the fingers and toes. Predisposing factors include age, gender, family history and smoking. Symptoms include fingers, toes, ears, or nose to become white, and then turn blue. Treatment includes vasodilator, alpha blockers and calcium channel blockers. The molecules developed by Companies in Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 2 and 2 respectively.

Furthermore, this report also reviews of key players involved in therapeutic development for Raynauds Disease and features dormant and discontinued projects.

Key Topics Covered:

  1. Introduction
  2. Raynauds Disease Overview
  3. Therapeutics Development
  4. Pipeline Products for Raynauds Disease - Overview
  5. Pipeline Products for Raynauds Disease - Comparative Analysis
  6. Raynauds Disease - Therapeutics under Development by Companies
  7. Raynauds Disease - Therapeutics under Investigation by Universities/Institutes
  8. Raynauds Disease Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Raynauds Disease - Products under Development by Companies
  13. Raynauds Disease - Products under Investigation by Universities/Institutes
  14. Raynauds Disease - Companies Involved in Therapeutics Development
  • Allergan Plc
  • Apricus Biosciences, Inc.
  • Covis Pharmaceuticals, Inc.
  • Human Stem Cells Institute

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.